A Precision Medicine Approach to Cognitive Decline
Pre-recorded breakout session workshops
Dale Bredesen, MD
UCLA and Buck Institute
Dr. Bredesen earned his MD from Duke University Medical Center and served as Chief Resident in Neurology at the University of California, San Francisco (UCSF), before joining Nobel laureate Stanley Prusiner’s laboratory at UCSF as an NIH Postdoctoral Fellow. He held faculty positions at UCSF, UCLA, and the University of California, San Diego. Dr. Bredesen also directed the Program on Aging at the Burnham Institute before joining the Buck Institute in 1998 as founding President and CEO.
Dr. Bredesen’s research explores previously uncharted territory in explaining the physical mechanism behind the erosion of memory seen in Alzheimer’s disease, and has opened the door to new approaches to treatment. This work has led to the identification of several new therapeutic processes that are showing remarkable early results. Dr. Bredesen is a prodigious innovator in medicine, with over thirty patents to his name. Notably, he put much of his findings and research into the 2017 New York Times‘ Best-Seller, The End of Alzheimer’s.
Professor, Department of Molecular and Medical Pharmacology
David Geffen School of Medicine UCLA
Founding President and Professor Emeritus
Buck Institute for Research on Aging
Author of the New York Times Bestseller, The End of Alzheimer's
A precision medicine approach to cognitive decline
- Identify the pathophysiology of Alzheimer’s
- Identify sub-typing of Alzheimer’s
- Utilize a personalized, precision protocol for cognitive decline.
- The End of Alzheimer's, Dr. Dale Bredesen